This inventor holds 2 USPTO granted patents. Top assignee: City University of Hong Kong. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Abhimanyu Thakur: Innovator in Exosomal Protein Detection
Introduction
Abhimanyu Thakur is a notable inventor based in West Bengal, India. He has made significant contributions to the field of biotechnology, particularly in the detection of exosomal proteins. With a total of 2 patents, his work is paving the way for advancements in non-invasive diagnostic methods.
Latest Patents
Thakur's latest patents include innovative methods and kits for detecting exosomal proteins. One of his patents describes a method that involves introducing a sample onto a first sensor with a nanostructure, subjecting it to optical radiation to produce localized surface plasmon resonance, and measuring the induced phase response. Additionally, it includes a second sensor for obtaining images via atomic force microscopy analysis with a probe functionalized with an antibody targeting the exosomal protein. Another patent focuses on a sensor for liquid biopsy, which is functionalized with biotinylated antibodies that engage with surface proteins on exosomes associated with malignant cancer cells, such as glioma cells.
Career Highlights
Abhimanyu Thakur is currently affiliated with the City University of Hong Kong, where he continues to advance his research in biotechnology. His work is instrumental in developing non-invasive diagnostic tools that could revolutionize cancer detection and treatment.
Collaborations
Thakur collaborates with esteemed colleagues, including Youngjin Lee and Chi-Man Lawrence Wu, who contribute to his research endeavors.
Conclusion
Abhimanyu Thakur's innovative work in the detection of exosomal proteins and liquid biopsy sensors highlights his significant role in advancing medical diagnostics. His contributions are expected to have a lasting impact on the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
